Skip to main content

Enovis to Showcase New 510(k) Cleared Foot & Ankle Products at the AOFAS Annual Meeting

Written by Customer Service on . Posted in Public Companies.

The expanding Foot & Ankle portfolio, including bracing, implants and boots, offers patients and surgeons a solution for every step of the way

Wilmington, DE, Sept. 08, 2022 (GLOBE NEWSWIRE) — Today, Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase its foot & ankle continuum of care portfolio at the American Orthopaedic Foot & Ankle Society® (AOFAS) annual meeting in Quebec City, Canada from September 14-17, 2022.

Enovis will feature several new products during an Industry Sponsored Workshop, Continuing Disruption: Latest Technologies in Foot & Ankle, highlighting recent FDA 510(k) cleared products, DynaClip Delta™ and DynaClip Quattro™. Attendees will be among the first to experience these products, along with DynaNail Helix™, during this hands-on workshop.

In addition to expansions of the company’s Active Adaptive product line, Enovis will also share the Future of STAR® Ankle during a second industry-sponsored workshop: First Glance at the Future of STAR.

“From introducing new applications to DynaNail and DynaClip, and expanding our Arsenal plating portfolio to the ankle, we continue to develop differentiating technologies that enable us to improve outcomes while living our purpose of creating better together,” said Gary Justak, President and General Manager of Enovis’ Foot & Ankle Division. “As committed, we will be extremely aggressive in our efforts to bring innovative technologies to market – including the future of our total ankle platform – and we are just getting started!”

Enovis will highlight products from its foot and ankle continuum of care including:

AOFAS Attendees have several opportunities throughout the week to experience these product offerings firsthand. Join one of the industry workshops and visit Booth 701 in the exhibit hall. Registration links and more information can be found here: www.djoglobal.com/aofas.

MK-10279

About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.

CONTACT: Megan Foltz
Enovis
(609) 680-0996
Megan.Foltz@enovis.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.